Joel Lewis, President and CEO: Galectin Therapeutics GALT Planned sale · Filed 25/12/17

Trade details

Type: Planned sale notice
Stock: Galectin Therapeutics GALT
Person: Joel LewisPresident and CEO
Planned sale date: 25/12/17
Filed: 25/12/17

More to sell after $244.2K in 3 months

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/17~01/16

Joel Lewis's recent trades

Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$135K
37,698 sh
$135K
Filed 01/06
Traded 01/06
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$108.4K
27,731 sh
$108.4K
Filed 01/06
Traded 01/05
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$78K
18,571 sh
$78K
Filed 01/06
Traded 01/02
Joel LewisPresident and CEO
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$352.8K
84,000 sh
$352.8K
Filed 01/02
Traded 01/02
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$55.3K
7,829 sh
$55.3K
Filed 25/12/19
Traded 25/12/17

Joel Lewis, CEO — plans to sell 40,000 sh of Galectin Therapeutics GALT · $282.2K · around 12/17 · 10b5-1 plan | Whalegun